Introduction: PerioChip a bovine origin gelatine based CHX chip has shown beneficial effects in the management of Chronic Periodontitis. A new fish collagen based CHX chip similar to PerioChip is currently available; however this product has not been thoroughly researched.

Aim: The aim of the present study was to evaluate the effectiveness of a new Piscean collagen-based controlled-release chlorhexidine chip (CHX chip) as an adjunctive therapy to scaling and root planing (SRP).

Settings And Design: The study was conducted as a randomised, split-mouth, controlled clinical trial at Krishnadevaraya College of Dental Sciences, Bangalore, India.

Materials And Methods: In a split-mouth study involving 20 sites in 10 patients with chronic periodontitis, control sites received scaling and root planing and test sites received scaling and root planing (SRP) and the intrapocket CHX chip placement as an adjunct. Subgingival plaque samples were collected from both control and test sites at baseline, 11 days and 11 weeks and the anaerobic colony count were assessed. Clinical parameters that were recorded at baseline and 11 weeks were gingival index, Plaque index, Probing pocket depth (PPD), and Clinical attachment level (CAL). Plaque index was recorded additionally at 11 days.

Results: In the test group there was a statistically significant reduction in the total anaerobic colony count, gingival index and plaque scores from baseline as compared to control sites at all time intervals. An additional 0.8mm reduction in mean probing pocket depth was noted in the test group. Gain in Clinical attachment level was comparable in both groups.

Conclusion: The adjunctive use of the new collagen-based CHX chip yielded significant antimicrobial benefit accompanied by a reduction in probing depth and a clinical attachment level gain as compared to SRP alone. This suggests that it may be a useful treatment option of nonsurgical periodontal treatment of chronic periodontitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484159PMC
http://dx.doi.org/10.7860/JCDR/2015/11534.5965DOI Listing

Publication Analysis

Top Keywords

chx chip
20
chronic periodontitis
16
scaling root
12
root planing
12
clinical attachment
12
attachment level
12
piscean collagen-based
8
collagen-based controlled-release
8
controlled-release chlorhexidine
8
chlorhexidine chip
8

Similar Publications

Our previous research identified that lncRNA PVT1 is upregulated in patients with IA. However, the precise functions of PVT1 in IA remain unclear. We compared the levels of PVT1, caspase-3, caspase-1, and NLRP3 in normal and IA patients.

View Article and Find Full Text PDF

This systematic review assesses the efficacy of local chlorhexidine (CHX) chips as an adjunct to nonsurgical scaling and root planing (SRP) in treating chronic periodontitis, compared to SRP alone. A comprehensive search strategy was developed to identify relevant studies, focusing on articles published in English. Searches were conducted in MEDLINE (via PubMed), Web of Science, and periodontology journals up to December 2020, specifically looking for studies on the use of CHX chips alongside SRP for managing chronic periodontitis.

View Article and Find Full Text PDF

HSP90 N-terminal inhibition promotes mitochondria-derived vesicles related metastasis by reducing TFEB transcription via decreased HSP90AA1-HCFC1 interaction in liver cancer.

Autophagy

November 2024

Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.

Cancer cells compensate with increasing mitochondria-derived vesicles (MDVs) to maintain mitochondrial homeostasis, when canonical MAP1LC3B/LC3B (microtubule associated protein 1 light chain 3 beta)-mediated mitophagy is lacking. MDVs promote the transport of mitochondrial components into extracellular vesicles (EVs) and induce tumor metastasis. Although HSP90 (heat shock protein 90) chaperones hundreds of client proteins and its inhibitors suppress tumors, HSP90 inhibitors-related chemotherapy is associated with unexpected metastasis.

View Article and Find Full Text PDF

To uncover the possible role of TRAF3IP3 in the progression of myocardial infarction (MI), clarify its role in mitophagy and mitochondrial function, and explore the underlying mechanism. GEO chip analysis, RT-qPCR, and LDH release assay were used to detect the expression of TRAF3IP3 in tissues and cells and its effects on cell damage. Immunostaining and ATP product assays were performed to examine the effects of TRAF3IP3 on mitochondrial function.

View Article and Find Full Text PDF

The novel suppresses autophagy degradation of BBC3 by preventing its interactions with HSPA8 to induce trophoblast cell apoptosis.

Autophagy

October 2024

Research Center for Environment and Female Reproductive Health, the Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.

Article Synopsis
  • - Abnormal levels of long non-coding RNAs (lncRNAs) in trophoblast cells are linked to miscarriages, with one specific lncRNA identified as being highly expressed in tissues from patients experiencing recurrent miscarriages compared to healthy controls.
  • - This lncRNA inhibits the degradation of BBC3 (a protein involved in cell death), which leads to increased apoptosis (cell death) in trophoblast cells, both of which are associated with miscarriage.
  • - Knocking down this lncRNA in a mouse model of miscarriage was shown to reduce placental apoptosis and improve pregnancy outcomes, suggesting both the lncRNA and BBC3 could be potential targets for treatment of miscarriages.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!